Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Sports Illustrated
Sports Illustrated
Sport
Madison Williams

Clayton Kershaw Shines in First Rehab Start While Recovering From Offseason Surgeries

Los Angeles Dodgers pitcher Clayton Kershaw makes a start for the Triple-A Oklahoma City Comets during a rehab assignment. | MLB/Screengrab

Clayton Kershaw made his 2025 debut on Wednesday for the Triple-A Oklahoma City Comets during a rehab assignment while he continues to recover from offseason surgeries on his knee and toe. It was his first start since Aug. 30, 2024.

The three time NL Cy Young Award winner started for the Comets on Wednesday vs. the Tacoma Raiders at home. Kershaw pitched three scoreless innings with two strikeouts. He was originally expected to throw for just around two innings. The Raiders did hit two singles off of Kershaw.

Kershaw's performance made Dodgers fans excited to see their ace back on the mound. He will be returning to the Dodgers on a one-year contract this season for his 18th year with the Dodgers.

With the start, Kershaw will be eligible to come off the 30-day rehab window on May 17. He's eligible to return to the Los Angeles Dodgers on May 17, as long as his recovery continues to progress.

Kershaw was limited to just seven games last season, pitching 30 innings while dealing with a torn meniscus and toe injury. He missed the Dodgers' entire postseason run to their World Series win, butstill earned a ring, which was the second of his career.


More MLB on Sports Illustrated


This article was originally published on www.si.com as Clayton Kershaw Shines in First Rehab Start While Recovering From Offseason Surgeries.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.